Inherent Biosciences: Funding, Investors & Team (Sep 2026)
Inherent Biosciences is a ground-breaking molecular diagnostics firm that aims to transform the realm of trial and error medicine and bring back optimism. By exploring the inherent aspects of our biology pertaining to unresolved issues, the company converts these discoveries into individualized knowledge that guides decision-making. Inherent Biosciences focuses on developing medications that address a wide range of conditions such as pain, infertility, embryo quality, autism, rheumatoid arthritis, psoriatic arthritis, fetal heart disease, COVID-19, and numerous others.
Inherent Biosciences has raised $1.9M across 3 funding rounds on record, the most recent an undisclosed round of $1.9M announced in Aug 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Inherent Biosciences Company Profile and Key Stats
Latest funding round on record: Aug 2023.
Inherent Biosciences Funding Rounds
2 of 3 rounds were announced without a disclosed amount and are excluded from the total.
Inherent Biosciences announced a Grant in Apr 2022; the amount was not disclosed.
5 months later, a Series A was announced in Sep 2022 with no disclosed amount.
11 months later, an undisclosed round of $1.9M was announced in Aug 2023.
Inherent Biosciences Founders and Leadership Team
Contact details for the Inherent Biosciences team: 2 of 2 have an email address on file.
Start 14-day free trial →Inherent Biosciences Funding Compared to Other Biotechnology Startups
Inherent Biosciences' latest round of $1.9M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Inherent Biosciences in Biotechnology and Salt Lake City
Companies Similar to Inherent Biosciences
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Inherent Biosciences Funding FAQs
What does Inherent Biosciences do?
Inherent Biosciences is a ground-breaking molecular diagnostics firm that aims to transform the realm of trial and error medicine and bring back optimism. By exploring the inherent aspects of our biology pertaining to unresolved issues, the company converts these discoveries into individualized knowledge that guides decision-making. Inherent Biosciences focuses on developing medications that address a wide range of conditions such as pain, infertility, embryo quality, autism, rheumatoid arthritis, psoriatic arthritis, fetal heart disease, COVID-19, and numerous others.
How much funding has Inherent Biosciences raised?
Inherent Biosciences has raised $1.9M across 3 rounds on record. The most recent is an undisclosed round of $1.9M announced in Aug 2023.
When did Inherent Biosciences last raise funding?
Inherent Biosciences' most recent funding round on record is an undisclosed round of $1.9M, announced in Aug 2023.
Who founded Inherent Biosciences?
FundedIQ lists Kristin Brogaard (Founder) at Inherent Biosciences.
Who is the CEO of Inherent Biosciences?
Andy Olson is listed as CEO at Inherent Biosciences.
Where is Inherent Biosciences headquartered?
Inherent Biosciences is based in Salt Lake City, Utah, United States.
How many employees does Inherent Biosciences have?
Inherent Biosciences is in the 11-50 employee band.
How does Inherent Biosciences' funding compare to other Biotechnology startups?
Inherent Biosciences' latest round of $1.9M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Inherent Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Inherent Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.